Purpose: In this study we aimed to investigate myocardial function and atrial electromechanical properties by conventional and tissue doppler echocardiography in patients with primary Sjögren syndrome.
Sjögren syndrome (SS) is a systemic autoimmune disease that primarily a ects lacrimal and salivary glands. [1] Because it is a systemic disease, SS may cause di erent organ involvement and di erent clinical manifestations. [1] [2] [3] [4] [5] SS is relatively frequent, with a prevelance of 0.05-4.8% and is primarily seen in middle aged women. [2, 6, 7] It can be primary or secondary to another connective tissue disease such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). [8] ere are substantial data in the literature about the untoward a ects of connective tissue diseases on the cardiovascular system: Levendoglu et al. showed ventricular dysfunction in RA patients [9] , Rexhepaj et al. showed that le ventricular diastolic dysfunction in RA patients can present even in the absence of clinically evident cardiovascular disease [10] , andCacciappuoti et al. showed disturbed myocardial performance index in SLE patients. [11] ere is some evidence concerning the role of in ammatory status on cardiac dysfunction in the literature. Di erent diseases may act on the cardiovascular system through the activity of mediators of in ammation. [12] [13] [14] A similar association is also found between in ammation and supraventricular arrhythmias. [15] Although data about how cardiovascular system is a ected in SS is limited, le ventricular systolic and diastolic dysfunction, pericardial e usion, pulmonary hypertension and valvular dysfunction have all been reported in patients with SS. [8, 16] Abnormalities in the conduction system and also in cardiomyocytes was shown by Inoue et al. and this may indicate that SS patients may be more prone to arrhythmias. [17] e purpose of this study is to further characterize the changes in the cardiovascular systems of SS patients by measuring both ventricular function and atrial electromechanical properties using conventional and tissue doppler echocardiography.
Materials and Methods
Forty patients with primary SS and 25 age-and sex-matched healthy volunteers were enrolled in the study. AmericanEuropean consensus criterias for primary SS [18] were accepted as diagnostic criteria. Any disease other than primary SS was accepted as an exclusion criterion (including hypertension and diabetes mellitus). Basal characteristics of all patients were recorded. Laboratory investigations (including hemogram, creatinine, lipid panel, hsCRP, anti SS-A/Ro and anti SS-B/La autoantibodies) were also performed.
Our study was approved by the local ethics committee and informed consent was obtained from all patients and healthy volunteers before enrollment in the study.
Echocardiography
Echocardiographic evaluation of patients was performed using a Vivid 7 echocardiography system (General Electric, Horten, Norway) with a 2.5-5 MHz tranducer. Echocardiographic examinations were performed by an experienced cardiologist who was blind to the patients and their characteristics. Patients were evaluated in the le lateral decubitus position.
rough all examinations a continuous one lead ECG was recorded. All parameters were calculated as the average of three consecutive beats. Dimensions of le ventricule (LV), septal wall (SW) and posterior wall (PW) thicknesses were measured by M-mode echocardiography in parasternal long axis view and LV ejection fraction (EF) was measured by modi ed Simpson's method.
For calculation of myocardial performance index (MPI) or Tei index [19] , both conventional method (cMPI) and tissue doppler method (tdMPI) were used. MPI was calculated according to following formula: [Isovolumic relaxation time (IVRT) + isovolumic contraction time (ICT)]/ejection time (ET).
To determine the electromechanic characteristics of the atria, tissue doppler was used. For all measurements, the apical four-chamber view was used. Myocardial systolic (S), early diastolic (E) and atrial systolic (A) waves were measured by pulsed wave (PW) doppler and E/A ratio was calculated. PW doppler measurements were then made at the lateral mitral annulus, septal mitral annulus and right ventricular (RV) tricuspid annulus. Time from the beginning of the P wave on the surface ECG to the beginning of the A wave was used as the PA interval and represented the atrial electromechanical delay. is time interval was calculated for lateral mitral annulus (lateral PA), septal mitral annulus (septal PA) and RV tricuspid annulus (tricuspid PA). Interatrial electromechanic delay (EMD) was accepted as lateral PA -tricuspid PA and intraatrial EMD was accepted as septal PA -tricuspid PA.
Statistical analysis
All statistical analysis were done using SPSS 17.0 (SPSS Inc., Chicago, Illinois, USA 
Results
Forty patients with primary SS and 25 healthy volunteers were included in the present study. Basal characteristics of participants are summarized in Table 1 . Mean age was 47.5±9.8 years in the SS group and 47.1±9.6 years in the control group (p>0.05). Female ratio was 90% in the SS group and 84% in the control group (p>0.05). Body mass index and laboratory parameters including hemoglobin, creatinine and lipid panel were similar between groups. Extraglandular manifestations were as follows: one patient had renal involvement, two patients had mild peripheral axonal neuropathy and two patients were diagnosed with cutaneous involvement. Of all the patients, 22 patients were receiving hydroxychloroquine, 11 patients were receiving prednisone plus hydroxychloroquine therapy, 2 patients were receiving azathiopurine and remaining 5 patients were on no speci c therapy. No subjects were using oral muscarinic agents.
Echocardiographic characteristics of groups are summarized in Table 2 . Although ejection fractions were similar between the groups, E/A ratios were lower in the SS group. Similarly, MPI values, which were measured by both conventional method and tissue doppler method, were reduced in patients with primary SS.
Atrial electromechanical characteristics of groups are also summarized in Table 2 . Interatrial EMD was signi cantly higher in the SS group compared with the control group (30.6±10.1, 15.4±5.9, respectively, p<0.01). Similarly, intraatrial EMD was also prolonged in SS group in comparison with the control group (16.4±6.4, 5.0±4.5, respectively, p<0.01).
ere was no signi cant relationship between SSA and SSB antibody positivity and MPI and atrial electromechanic properties. 
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Discussion
In the present study, myocardial functions and atrial electromechanic characteristics were investigated in primary SS patients. MPI is increased in primary SS and there is signi cant atrial electromechanical delay in this patient group, compared with the control group. Sjögren sydrome is one of the systemic autoimmune diseases that primarily a ects exocrine glands but can also have a variety of di erent organ involvement. [1] Although there have been many studies describing the characteristics of cardiac involvement of systemic autoimmune diseases, there is little known about the e ects of SS. For example; Alpaslan et al. conducted a study on RA patients and found le ventricular diastolic dysfunction in this patient group. 20 Plazak and his collegues showed that le ventricular dysfunction may be more prevalent in a spectrum of di erent autoimmune diseases. [14] Rosato et al. found regional diastolic dysfunction by tissue doppler echocardiography in patients with systemic sclerosis (SSc) and Paradisp et al. showed disturbed le ventricular lling patterns in SLE patients. [21, 22] It is clear that le ventricular dysfunction is relatively frequent in in ammatory autoimmmune diseases. Myocardial dysfunction can be a result of myocarditis, myocardial brosis, vasculitis or microvascular dysfunction in these patients, but it can also be secondary to general subclinical or clinical in ammatory status. [14, [23] [24] [25] [26] Liang et al. showed that diastolic dysfunction is much more prevelant in patients with RA and they concluded that this may potentially be due to chronic autoimmune in ammation. [27] ey found a signi cant relationship between IL-6 and le ventricular diastolic dysfunction. Rosato et al. proposed immunoin ammatory damage as one of the causes of myocardial dysfunction in SSc. [21] e relationship between in ammation and myocardial dysfunction was also investigated in di ererent patient groups. Lee et al. found a signi cant relationship between in ammatory status and le ventricular diastolic dysfunction, and they proposed that TNF-α may aggrevate diastolic dysfunction. [13] Pentraxin 3, which is a novel in ammatory marker, has also been shown to be signi cantly increased in the presence of le ventricular dysfunction and diastolic heart failure. [28] In our study, the causes of myocardial dysfunction in SS patients were not investigated; rather, the characteristics of le ventricular functions were evaluated in our patient group. From a mechanistic point of view, the in ammatory mechanisms in the pathophysiology of SS may play a role in myocardial dysfunction.
In our study, the atrial electromechanic characteristics showed signi cant atrial electromechanic delay (AEMD) in patients with SS compared with the healthy control group.
Because increased AEMD is a predictor of atrial brillation, patients with SS may be more prone to this kind of arrhythmia. Similar results were also found in other autoimmune diseases. Stojanovich et al. investigated autonomic functions in patients with RA, SLE, SSc and primary SS and they found cardiac autonomic dysfunction in these patients. [29] Aktoz et al. showed signi cant AEMD in patients with SSc compared with the control group. 30 e increased AEMD in our patient group might be result of disturbed myocardial functions and the results of a study by Yavuz et al,. which show that diastolic dysfunction is closely associated with atrial electromechanical characteristics, support our hypothesis. [31] Because there are few reports regarding the relationship between the anti-SS-A antibody and QT prolongation, we thought that there may be relationship between anti SS-A antibody and atrial electromechanical properties or myocardial functional parameters, [32, 33] but no signi cant relationship was found between the anti-SS-A/SS-B antibodies and atrial electromechanic and myocardial functional properties.
ere are some limitations of our study. First, participant number is relatively low. Second, the in ammatory markers that could play role in myocardial dysfunction were not measured. e aim of our study was to investigate myocardial and atrial electromechanical functions, and not to nd the causes of myocardial dysfunction. In conclusion, myocardial functions are disturbed and there is signi cant AEMD in patients with primary SS. Clinical and prognostic signi cance of AEMD prolongation and subclinical myocardial dysfunction cannot yet be de ned. ese ndings are important because this study is the rst to detail myocardial dysfunction and atrial electromechanic delay in primary SS patients.
